Mustang Bio, Inc. EPS (Diluted, from Cont. Ops)

EPS (Diluted, from Cont. Ops) of MBIO for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted, from Cont. Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Diluted, from Cont. Ops) for the quarter ending March 31, 2022 was $-0.202 (a -7.54% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted, from Cont. Ops) increased by 23.29%
  • Annual EPS (Diluted, from Cont. Ops) for 2021 was $-0.755 (a -33.82% decrease from previous year)
  • Annual EPS (Diluted, from Cont. Ops) for 2020 was $-1.14 (a -11.29% decrease from previous year)
  • Annual EPS (Diluted, from Cont. Ops) for 2019 was $-1.29 (a 13.06% increase from previous year)
  • Twelve month EPS (Diluted, from Cont. Ops) ending March 31, 2022 was $-0.772 (a 2.16% increase compared to previous quarter)
  • Twelve month trailing EPS (Diluted, from Cont. Ops) decreased by -12.76% year-over-year
Trailing EPS (Diluted, from Cont. Ops) for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$-0.772 $-0.755 $-0.845 $-0.884
Visit stockrow.com/MBIO for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted, from Cont. Ops) of Mustang Bio, Inc.

Most recent EPS (Diluted, from Cont. Ops)of MBIO including historical data for past 10 years.

Interactive Chart of EPS (Diluted, from Cont. Ops) of Mustang Bio, Inc.

Mustang Bio, Inc. EPS (Diluted, from Cont. Ops) for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0
2021 $0.0 $0.0 $0.0 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0 $0.0
2019 $0.0 $0.0 $0.0 $0.0 $0.0
2018 $0.0 $0.0 $0.0 $0.0 $0.0
2017 $0.0 $0.0 $0.0 $0.0 $0.0
2016 $0.0 $0.0 $0.0 $0.0 $0.0
2015 $0.0

Business Profile of Mustang Bio, Inc.

Sector: Healthcare
Industry: Biotechnology